These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 14557130)

  • 1. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.
    Freise CE; Kang SM; Feng S; Hirose R; Stock P
    Arch Surg; 2003 Oct; 138(10):1121-5; discussion 1125-6. PubMed ID: 14557130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
    Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
    Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous kidney-pancreas transplantation without antilymphocyte induction.
    Reddy KS; Stratta RJ; Shokouh-Amiri H; Alloway R; Somerville T; Egidi MF; Gaber LW; Gaber AO
    Transplantation; 2000 Jan; 69(1):49-54. PubMed ID: 10653379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial outcomes of a steroid-free regimen with thymoglobulin induction in pancreas-kidney transplantation.
    Tanchanco R; Krishnamurthi V; Winans C; Wee A; Duclos A; Nurko S; Fatica R; Lard M; Poggio ED
    Transplant Proc; 2008 Jun; 40(5):1551-4. PubMed ID: 18589149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin.
    Reddy KS; Devarapalli Y; Mazur M; Hamawi K; Chakkera H; Moss A; Mekeel K; Post D; Heilman R; Mulligan D
    Transplant Proc; 2010; 42(6):2006-8. PubMed ID: 20692393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco.
    Vincenti F; Stock P
    Transplant Proc; 2003 May; 35(3 Suppl):183S-186S. PubMed ID: 12742494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.
    Rajab A; Pelletier RP; Ferguson RM; Elkhammas EA; Bumgardner GL; Henry ML
    Transplantation; 2007 Nov; 84(9):1131-7. PubMed ID: 17998868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of pancreas transplantation under tacrolius immunosuppression.
    Jordan ML; Shapiro R; Gritsch HA; Egidi F; Khanna A; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ
    Transplantation; 1999 Jan; 67(2):266-72. PubMed ID: 10075592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.
    Trofe J; Stratta RJ; Egidi MF; Lo A; Gaber LW; Shokouh-Amiri MH; Grewal HP; Honaker M; Hardinger K; Alloway RR; Gaber AO
    Clin Transplant; 2002; 16 Suppl 7():34-44. PubMed ID: 12372042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy.
    Vessal G; Wiland AM; Philosophe B; Fink JC; Weir MR; Klassen DK
    Clin Transplant; 2007; 21(4):491-7. PubMed ID: 17645708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression.
    Stratta RJ; Lo A; Shokouh-Amiri MH; Egidi MF; Gaber LW; Gaber AO
    Transpl Int; 2003 Mar; 16(3):154-60. PubMed ID: 12664209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation.
    Uemura T; Ramprasad V; Matsushima K; Shike H; Valania T; Kwon O; Ghahramani N; Shah R; Farooq U; Khan A; Kadry Z
    Transplantation; 2011 Sep; 92(6):678-85. PubMed ID: 21841541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression.
    Stratta RJ; Shokouh-Amiri MH; Egidi MF; Grewal HP; Lo A; Kizilisik AT; Nezakatgoo N; Gaber LW; Gaber AO
    Clin Transplant; 2003; 17 Suppl 9():69-77. PubMed ID: 12795673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis.
    Kandaswamy R; Melancon JK; Dunn T; Tan M; Casingal V; Humar A; Payne WD; Gruessner RW; Dunn DL; Najarian JS; Sutherland DE; Gillingham KJ; Matas AJ
    Am J Transplant; 2005 Jun; 5(6):1529-36. PubMed ID: 15888064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
    Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
    Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
    Jordan ML; Chakrabarti P; Luke P; Shapiro R; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ
    Transplantation; 2000 Jan; 69(2):265-71. PubMed ID: 10670637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate.
    Tanriover B; Jaikaransingh V; MacConmara MP; Parekh JR; Levea SL; Ariyamuthu VK; Zhang S; Gao A; Ayvaci MUS; Sandikci B; Rajora N; Ahmed V; Lu CY; Mohan S; Vazquez MA
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1650-1661. PubMed ID: 27364616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.